SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001741830-21-000040
Filing Date
2021-08-12
Accepted
2021-08-12 16:29:47
Documents
14
Period of Report
2021-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kron-20210812.htm   iXBRL 8-K 36606
2 EX-99.1 kron2q21ex-991.htm EX-99.1 59463
6 image_0.jpg GRAPHIC 30771
  Complete submission text file 0001741830-21-000040.txt   291856

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kron-20210812.xsd EX-101.SCH 1930
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kron-20210812_lab.xml EX-101.LAB 25998
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kron-20210812_pre.xml EX-101.PRE 13745
7 EXTRACTED XBRL INSTANCE DOCUMENT kron-20210812_htm.xml XML 11628
Mailing Address 1300 S. EL CAMINO REAL SUITE 300 SAN MATEO CA 94402
Business Address 1300 S. EL CAMINO REAL SUITE 300 SAN MATEO CA 94402 212-871-7920
Kronos Bio, Inc. (Filer) CIK: 0001741830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39592 | Film No.: 211168012
SIC: 2834 Pharmaceutical Preparations